C01G49/06

Iron oxide magnetic particles

The present invention provides iron oxide magnetic particles including an iron oxide and MX.sub.n, wherein M includes one or more selected from the group consisting of Cu, Sn, Pb, Mn, Ir, Pt, Rh, Re, Ag, Au, Pd, and Os, X includes one or more selected from the group consisting of F, Cl, Br, and I, and n is an integer of 1 to 6.

Methods of producing hydrogen-selective oxygen carrier materials

Embodiments of the present disclosure are directed to methods of producing a hydrogen-selective oxygen carrier material comprising combining one or more core material precursors and one or more shell material precursors to from a precursor mixture and heat-treating the precursor mixture at a treatment temperature to form the hydrogen-selective oxygen carrier material. The treatment temperature is greater than or equal to 100° C. less than the melting point of a shell material, and the hydrogen-selective oxygen carrier material comprises a core comprising a core material and a shell comprising the shell material. The shell material may be in direct contact with at least a majority of an outer surface of the core material.

Methods of producing hydrogen-selective oxygen carrier materials

Embodiments of the present disclosure are directed to methods of producing a hydrogen-selective oxygen carrier material comprising combining one or more core material precursors and one or more shell material precursors to from a precursor mixture and heat-treating the precursor mixture at a treatment temperature to form the hydrogen-selective oxygen carrier material. The treatment temperature is greater than or equal to 100° C. less than the melting point of a shell material, and the hydrogen-selective oxygen carrier material comprises a core comprising a core material and a shell comprising the shell material. The shell material may be in direct contact with at least a majority of an outer surface of the core material.

Method for treating a biofilm

A method of preparing iron oxide nanoparticles using an herbal mixture comprising Capparis spinosa, Cichorium intybus, Solanum nigrum, Cassia occidentalis, Terminalia arjuna, Achillea millefolium, and Tamarix gallica. The method produces crystalline γ-Fe.sub.2O.sub.3 nanoparticles which are superparamagnetic. The iron oxide nanoparticles are used in a method of killing or inhibiting the growth of a bacteria and/or fungus, particularly in the form of a biofilm. The nanoparticles are also used in a method of treating colon cancer.

Method for treating a biofilm

A method of preparing iron oxide nanoparticles using an herbal mixture comprising Capparis spinosa, Cichorium intybus, Solanum nigrum, Cassia occidentalis, Terminalia arjuna, Achillea millefolium, and Tamarix gallica. The method produces crystalline γ-Fe.sub.2O.sub.3 nanoparticles which are superparamagnetic. The iron oxide nanoparticles are used in a method of killing or inhibiting the growth of a bacteria and/or fungus, particularly in the form of a biofilm. The nanoparticles are also used in a method of treating colon cancer.

METHODS FOR CATALYTICALLY REDUCING A NITRO COMPOUND

A thermal method of forming ferric oxide nano/microparticles with predominant morphology is described using different solvents. Methods of using the Fe.sub.3O.sub.4 nano/microparticles as catalysts in the reduction of nitro compounds with sodium borohydride to the corresponding amines and decomposition of ammonium salts.

METHODS FOR CATALYTICALLY REDUCING A NITRO COMPOUND

A thermal method of forming ferric oxide nano/microparticles with predominant morphology is described using different solvents. Methods of using the Fe.sub.3O.sub.4 nano/microparticles as catalysts in the reduction of nitro compounds with sodium borohydride to the corresponding amines and decomposition of ammonium salts.

IRON OXIDE PIGMENTS CONTAINING AL

Aluminium-containing iron oxide pigments of the formula Fe.sub.2-xAl.sub.xO.sub.3 with x values from 0.01 to 0.25, characterized in that they possess an a* value of 30.5 to 32.5 CIELAB units and a b* value of 25.5 to 30.5 CIELAB units, measured in each case as full shade in the alkyd resin according to DIN EN ISO 787-25:2007.

Powder of β-iron oxyhydroxide-based compound, β-iron oxyhydroxide-based compound sol, manufacturing method of powder of ϵ-iron oxide-based compound, and manufacturing method of magnetic recording medium
11440810 · 2022-09-13 · ·

Provided is a powder of a β-iron oxyhydroxide-based compound that is a group of particles of a β-iron oxyhydroxide-based compound represented by Formula (1) below; in which a surface of the particles of the β-iron oxyhydroxide-based compound is modified with a surface modifier; in which, in a case where the powder is dispersed in water to be made into a sol, a zeta potential of the powder is equal to or higher than +5 mV at pH 10; and
β-A.sub.aFe.sub.1-aOOH  (1)
in which, in Formula (1), A represents at least one metallic element other than Fe, and a represents a number that satisfies a relationship of 0≤a<1.

Powder of β-iron oxyhydroxide-based compound, β-iron oxyhydroxide-based compound sol, manufacturing method of powder of ϵ-iron oxide-based compound, and manufacturing method of magnetic recording medium
11440810 · 2022-09-13 · ·

Provided is a powder of a β-iron oxyhydroxide-based compound that is a group of particles of a β-iron oxyhydroxide-based compound represented by Formula (1) below; in which a surface of the particles of the β-iron oxyhydroxide-based compound is modified with a surface modifier; in which, in a case where the powder is dispersed in water to be made into a sol, a zeta potential of the powder is equal to or higher than +5 mV at pH 10; and
β-A.sub.aFe.sub.1-aOOH  (1)
in which, in Formula (1), A represents at least one metallic element other than Fe, and a represents a number that satisfies a relationship of 0≤a<1.